Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients

被引：0
|
作者：
Ghavamzadeh, A. [1 ]
Alimogaddam, K. [1 ]
Khatami, F. [1 ]
Gaffari, F. [1 ]
Ashuri, A. [1 ]
Mousavi, A. [1 ]
Iravani, M. [1 ]
Bahar, B. [1 ]
Jahani, M. [1 ]
Khodabande, A. [1 ]
机构：
[1] Hematol Oncol & Bone Marrow Transplantat Res Ctr, Tehran, Iran
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [41] High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma
    谷景立
    China Medical Abstracts(Internal Medicine), 2019, 36 (04) : 230 - 231
  • [42] Alpha n intravenous busulfan based myeloablative conditioning regimen for allogeneic haematopoietic stem cell transplantation in paediatric ALL patients
    Paisiou, A.
    Peristeri, I.
    Kitra, V.
    Vessalas, G.
    Dimopoulou, M.
    Graphakos, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S103 - S103
  • [43] Allogeneic and autologous stem cell transplantation for chronic myelogenous leukaemia
    Mistrik, M
    Hrubisko, M
    Demeckova, E
    Bojtarova, E
    Kotoucek, P
    Czako, B
    Nachtmanova, K
    Chabronova, J
    Gubkova, M
    Avramovova, M
    Jankovicova, D
    Martinka, J
    Kusikova, M
    Stemnicka, D
    Batorova, A
    Skrakova, M
    Pavlikova, D
    Cupanikova, D
    Fehervizyova, E
    BONE MARROW TRANSPLANTATION, 2005, 35 : S381 - S381
  • [44] Continuous High-Dose Idarubicin and Busulfan As Conditioning Regimen for Chinese Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation
    Ming, Hong
    Qian, Sixuan
    Peng, Liu
    Wu Hanxin
    Qiu Hongxia
    Hua, Lu
    Zhang Sujiang
    Wei, Xu
    BLOOD, 2012, 120 (21)
  • [45] Fludarabine with i.v. busulfan as novel conditioning regimen therapy for autologous stem cell transplantation in patients with acute non-lymphoid leukaemia: a single-centre experience
    Console, G.
    Messina, G.
    Moscato, T.
    Martino, M.
    Fedele, R.
    Massara, E.
    Princi, D.
    Irrera, G.
    Redaelli, G.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S281 - S282
  • [46] Conditioning with targeted peripheral blood stem cells busulfan for autologous transplantation for acute myelogenous leukemia in an XYY male
    Sada, E
    Henzan, H
    Ohtani, R
    Takase, K
    Miyamoto, T
    Fukuda, T
    Nagafuji, K
    Yamauchi, K
    Takamatsu, Y
    Inaba, S
    Harada, M
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (01) : 55 - 58
  • [47] Results of two conditioning regimen followed by autologous haematopoietic stem cell transplantation in patients with pharmacoresistant forms of multiple sclerosis
    Motuzova, Y.
    Fedulau, A.
    Uss, A.
    Milanovich, N.
    Baida, A.
    Drazhina, L.
    Minzer, M.
    Chernysh, E.
    Bulaev, I.
    Smolnikova, V.
    Volkovetz, N.
    Morozova, O.
    Solovyova, N.
    Borisov, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 263 - 263
  • [48] Comparison of intravenous versus oral busulfan on the prognosis of paediatric patients with acute leukaemia undergoing haematopoietic stem cell transplantation
    Hamidieh, A.
    Behfar, M.
    Tayebi, S.
    Jalali, A.
    Aliabadi, L. Sharifi
    Hosseini, A.
    Basirpanah, S.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S227 - S227
  • [49] Haematopoietic stem cell transplantation in paediatrics with acute leukaemia
    Hamidieh, A. A.
    Ghavamzadeh, A.
    Jahani, M.
    Alimoghaddam, K.
    Mosavi, A.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Jalili, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S381 - S381
  • [50] Progenitor cell transplantation (PCT) in children with a conditioning regimen of busulfan, cyclophosphamide and etoposide.
    Mustafa, MM
    El Solh, H
    Ayas, M
    Al-Mahr, M
    Al-Jefri
    BLOOD, 1998, 92 (10) : 353B - 353B
12345